Nishihara K, Kohda Y, Saitoh Y, Nakagawa F, Honda Y
Ther Drug Monit. 1984;6(2):232-7. doi: 10.1097/00007691-198406000-00018.
A new determination method of pemoline in plasma, plasma water, mixed saliva, and urine using high-performance liquid chromatography was developed. The detection limit of pemoline using 0.2 ml of the sample was 0.02 microgram/ml in plasma, plasma water, saliva, and urine. The recoveries of pemoline added to plasma, saliva, and urine (each 6 micrograms/ml) were more than 98%. The coefficients of variation of within-run and between-run precisions for 5 concentrations of pemoline in plasma were less than 5 and 6%, respectively. The elimination half-lives of pemoline obtained from the plasma concentration-time curves after a single oral administration of pemoline in two subjects were 6.7 and 10.3 h. Mean values of the ratio between saliva and plasma total concentration in two subjects were 0.55 and 0.64, and mean values of plasma protein binding percent were 35.7 and 25.2%, respectively. The saliva concentrations were in proportion to the plasma unbound pemoline concentrations at simultaneous samplings, and the ratios between saliva and plasma unbound concentration were about 0.9 in two subjects. Usefulness of saliva in the estimation of plasma protein-unbound pemoline concentration was noted.
建立了一种采用高效液相色谱法测定血浆、血浆水、混合唾液和尿液中匹莫林的新方法。使用0.2 ml样品时,匹莫林在血浆、血浆水、唾液和尿液中的检测限为0.02微克/毫升。添加到血浆、唾液和尿液(均为6微克/毫升)中的匹莫林回收率均超过98%。血浆中5种浓度匹莫林的批内和批间精密度变异系数分别小于5%和6%。在两名受试者单次口服匹莫林后,根据血浆浓度-时间曲线得到的匹莫林消除半衰期分别为6.7小时和10.3小时。两名受试者唾液与血浆总浓度之比的平均值分别为0.55和0.64,血浆蛋白结合率的平均值分别为35.7%和25.2%。在同时采样时,唾液浓度与血浆中未结合的匹莫林浓度成正比,两名受试者唾液与血浆未结合浓度之比约为0.9。发现唾液在估计血浆中未结合的匹莫林浓度方面具有实用性。